Submit press releases and photos to Medical Device News Magazine. Our objective is to keep medical specialists informed on the latest breakthroughs, clinical trials and more. All press releases will be reviewed by our editorial team. Note that there are no guarantees that your press release will be posted. Embargoed news will be honored. Inquire regarding byline opportunities.
If you are interested in our advertising and marketing opportunities, please visit here.
Details on where to send your press release is noted below:
1/18/19: As part of the investment, which is detailed in a Form 8-K filed with the United States Securities and Exchange Commission on January 14, 2019, Mr. Schwartz also received additional warrants to purchase Company common stock.
1/18/19: The study showed the technology to be about 89 percent accurate in automatic tracking of digested calories. A 14-day study was completed by 27 adult volunteers between the ages of 18-40 years old, 11 men and 16 women.
1/18/19: Proceeds from the financing will be used to complete the development of the company’s transcatheter transseptal mitral valve implantation program, which includes regulatory approval trials in Europe to obtain the CE mark and a first clinical trial in the U.S. via an Early Feasibility Study.